Natco Pharma shares jump 5% as company files for generic cancer drug approval with USFDA 0 30.08.2024 09:32 Economictimes.indiatimes.com Natco Pharma shares surged 5% to Rs 1,569 after filing an ANDA with the US FDA for a generic cancer drug. The company aims for 180 days of marketing exclusivity. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
